newsfilter
← Latest News
PR Newswire·

Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference

  • Precigen, Inc. (Nasdaq: PGEN) announced that CEO Helen Sabzevari, PhD, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco from January 12–15, 2026.
  • Dr. Sabzevari's company presentation is scheduled for Thursday, January 15, 2026, at 7:30 AM PT.
  • Dr. Sabzevari will also participate in a fireside chat with commercialization partner Eversana on Monday, January 12, 2026, at 10:30 AM PT at the Biotech Showcase.
  • Event details are available on Precigen's website under the Events & Presentations section at investors.precigen.com/events-presentations.
  • Precigen is a biopharmaceutical company developing precision medicines in immuno-oncology, autoimmune disorders, & infectious diseases.
  • The press release includes a cautionary statement regarding forward-looking statements about the commercialization of PAPZIMEOS™ for recurrent respiratory papillomatosis (RRP).